Individualizing drug therapy for the hypertensive patient.
When prescribing antihypertensive agents, the clinician must take into account coexisting conditions, lest treatment produce adverse, perhaps even life-threatening, side effects. The preferred agents and those to be avoided are discussed for six associated pathologies. Available drug options now permit tailored therapy that not only lowers blood pressure but also minimizes organ damage.
Bravo
E L
EL
Endocrine/Hypertension Laboratory, Cleveland Clinic Research Institute.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006937:Hypercholesterolemia / Q000209:etiology; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000209:etiology; D007333:Insulin Resistance; D009203:Myocardial Infarction / Q000209:etiology; D009400:Nephrosclerosis / Q000209:etiology; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000209:etiology
D000959:Antihypertensive Agents